瘤学家对脊髓转移患者的六个月生存预测显示出可靠的预后
Kofi Cox1, Hassam Ahmed1, Priyanshu Saha1
1Department of Medicine, St. George's University of London, London, UK.
Global spine journal
|November 27, 2023
概括
癌症专家对转移性脊髓压缩 (MSCC) 的预测准确地预测了患者的存活率. 这一发现支持在MSCC管理中使用临床判断而不是可能过时的评分系统来及时做出治疗决策.
科学领域:
- 在瘤学瘤学.
- 临床决策 临床决策
- 癌症预后 癌症预后
背景情况:
- 转移性脊髓压缩 (MSCC) 管理依赖于预后评分系统.
- 现有的评分系统可能无法反映当代癌症治疗的进步.
- 瘤学家提供的预后对于MSCC的快速临床决策至关重要.
研究的目的:
- 以回顾评估瘤学家提供的预后与MSCC患者实际生存结果的准确性.
- 评估临床预后在不断发展的癌症治疗的背景下发挥的作用.
主要方法:
- 对829名MSCC患者的回顾性分析,这些患者被转移到多学科团队 (MDT).
- 患者分为<6个月和>6个月的预后组.
- 进行了中位数整体存活 (mOS),危险比 (HR) 和接收器操作特征 (ROC) 分析.
主要成果:
- 在<6个月的预后组中,总生存时间的中位数为5.8个月;在>6个月的预后组中,生存时间没有达到.
- 记录等级测试 (Chi2=131,P<.001) 和考克斯回归 (HR=.30,P<.001) 显示出显著的预后准确性.
- 在ROC曲线下的面积为78%,显示出良好的预测性能.
结论:
- 瘤学家提供的预后对于未经选择的MSCC患者来说是准确和可靠的.
- 临床预后减少了对可能过时的预后评分系统的依赖.
- 准确的瘤学家预后对于高效的MSCC管理和手术候选人确定至关重要.
相关概念视频
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Assumptions of Survival Analysis
134
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
134
Kaplan-Meier Approach
152
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
152


